# Long-term Prognosis of Children With Bronchiectasis Treated With Low-dose Erythromycin Intervention

> **NCT03966066** · NA · UNKNOWN · sponsor: **Beijing Children's Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Bronchiectasis

## Interventions

- **DRUG:** erythromycin

## Key facts

- **NCT ID:** NCT03966066
- **Lead sponsor:** Beijing Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08
- **Primary completion:** 2020-07
- **Final completion:** 2020-07
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2019-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03966066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03966066, "Long-term Prognosis of Children With Bronchiectasis Treated With Low-dose Erythromycin Intervention". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03966066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*